Julien Bezin

1.8k total citations · 2 hit papers
67 papers, 1.2k citations indexed

About

Julien Bezin is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Toxicology. According to data from OpenAlex, Julien Bezin has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 13 papers in Cardiology and Cardiovascular Medicine and 13 papers in Toxicology. Recurrent topics in Julien Bezin's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Pharmacovigilance and Adverse Drug Reactions (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Julien Bezin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Pharmacovigilance and Adverse Drug Reactions (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Julien Bezin collaborates with scholars based in France, United Kingdom and Italy. Julien Bezin's co-authors include Alexandre Pariente, Nicholas Moore, R. Lassalle, Patrick Blin, Mai Duong, Jean‐Luc Faillie, Sandy Maumus‐Robert, Amandine Gouverneur, Clément Mathieu and Dominique Hillaire‐Buys and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and BMJ.

In The Last Decade

Julien Bezin

58 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

2017 398 citations Julien Bezin, R. Lassalle et al. profile →
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

2022 184 citations Julien Bezin, Amandine Gouverneur et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julien Bezin France	18	251	186	182	175	157	67	1.2k
Carmen Ferrajolo Italy	24	139 0.6×	87 0.5×	89 0.5×	151 0.9×	175 1.1×	56	1.4k
Ida Fortino Italy	24	275 1.1×	337 1.8×	450 2.5×	280 1.6×	217 1.4×	108	1.9k
Michele M. Spence United States	13	151 0.6×	143 0.8×	265 1.5×	181 1.0×	70 0.4×	24	1.2k
Liberata Sportiello Italy	24	363 1.4×	52 0.3×	149 0.8×	78 0.4×	235 1.5×	76	1.6k
Morten Hansen Denmark	17	420 1.7×	216 1.2×	153 0.8×	110 0.6×	257 1.6×	45	1.2k
A. J. Porsius Netherlands	17	226 0.9×	369 2.0×	296 1.6×	178 1.0×	104 0.7×	56	1.4k
Stephanie H. Read United Kingdom	20	478 1.9×	80 0.4×	282 1.5×	108 0.6×	203 1.3×	51	1.4k
Luca Degli Esposti Italy	20	318 1.3×	178 1.0×	540 3.0×	295 1.7×	80 0.5×	200	1.7k
Arja Helin‐Salmivaara Finland	19	98 0.4×	175 0.9×	285 1.6×	375 2.1×	78 0.5×	37	1.4k
Luisa Ibáñez Spain	21	68 0.3×	114 0.6×	171 0.9×	60 0.3×	66 0.4×	52	1.4k

Countries citing papers authored by Julien Bezin

Since Specialization

Citations

This map shows the geographic impact of Julien Bezin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Bezin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Bezin more than expected).

Fields of papers citing papers by Julien Bezin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Bezin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Bezin. The network helps show where Julien Bezin may publish in the future.

Co-authorship network of co-authors of Julien Bezin

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Bezin. A scholar is included among the top collaborators of Julien Bezin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Bezin. Julien Bezin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saillour-Glenisson, Florence, et al.. (2025). Sex Differences in the Use and Discontinuation of Recommended Drugs in Secondary Ischemic Stroke Prevention: A Regional Registry-Based Analysis. Journal of Women s Health. 35(3). 264–270.

Justice, Amy C., Kirsha S. Gordon, Melissa Skanderson, et al.. (2024). Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort Study. Journal of General Internal Medicine. 39(16). 3261–3270. 2 indexed citations

Constans, J., Carine Boulon, Caroline Caradu, et al.. (2023). Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry. JMV-Journal de Médecine Vasculaire. 48(5-6). 163–173.

Ong, Natalie, et al.. (2023). General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. International Journal of Drug Policy. 118. 104082–104082. 6 indexed citations

Tournier, Marie, Anne Bénard‐Laribière, Fabrice Jollant, et al.. (2023). Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study. Acta Psychiatrica Scandinavica. 148(3). 233–241. 20 indexed citations

Maumus‐Robert, Sandy, et al.. (2023). Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting. Frontiers in Endocrinology. 14. 1254221–1254221. 1 indexed citations

Mathieu, Clément, Élodie Pambrun, Anne Bénard‐Laribière, et al.. (2022). Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study. European Journal of Epidemiology. 37(10). 1049–1059. 15 indexed citations

Renard, Mathilde, et al.. (2022). Systematic review on sex differences for drug use after stroke. Therapies. 78(2). 213–224. 1 indexed citations

Linard, Morgane, Julien Bezin, Pierre Joly, et al.. (2022). Antiherpetic drugs: a potential way to prevent Alzheimer’s disease?. Alzheimer s Research & Therapy. 14(1). 3–3. 20 indexed citations

10.

Maumus‐Robert, Sandy, et al.. (2021). Chronic polypharmacy at all age: A population‐based drug utilization study. Fundamental and Clinical Pharmacology. 36(2). 405–413. 6 indexed citations

11.

Gouverneur, Amandine, Paola Sanchez-Peña, G. Veyrac, et al.. (2021). Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis. Cardiovascular Drugs and Therapy. 37(2). 271–276. 7 indexed citations

12.

Mathieu, Clément, M Arnaud, Emanuel Raschi, et al.. (2020). Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis. Pharmacological Research. 160. 105089–105089. 3 indexed citations

13.

Pariente, Alexandre, Yohann Mansiaux, Francesco Salvo, et al.. (2020). DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus. Drug Safety. 43(8). 767–774. 6 indexed citations

14.

Maumus‐Robert, Sandy, et al.. (2020). The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy. Journal of Clinical Medicine. 9(11). 3728–3728. 24 indexed citations

15.

Maumus‐Robert, Sandy, et al.. (2019). Polypharmacy: A general review of definitions, descriptions and determinants. Therapies. 75(5). 407–416. 68 indexed citations

16.

Bezin, Julien & Nicholas Moore. (2019). Pharmacoepidemiology of statins. Therapies. 74(2). 261–269. 4 indexed citations

17.

Pariente, Alexandre, Yohann Mansiaux, Francesco Salvo, et al.. (2017). Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients. European Journal of Clinical Pharmacology. 73(12). 1655–1663. 4 indexed citations

18.

Bezin, Julien, Florence Francis-Oliviero, Philip Robinson, et al.. (2016). Impact of a public media event on the use of statins in the French population. Archives of cardiovascular diseases. 110(2). 91–98. 17 indexed citations

19.

Verdoux, Hélène, Élodie Pambrun, Marie Tournier, Julien Bezin, & Alexandre Pariente. (2016). Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation. Schizophrenia Research. 178(1-3). 58–63. 28 indexed citations

20.

Bezin, Julien, Alexandre Pariente, R. Lassalle, et al.. (2013). Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. European Journal of Clinical Pharmacology. 70(4). 429–436. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact